OC
VVUS

Oppenheimer & Co’s Vivus Inc VVUS Stock Holding History

Oppenheimer & Co’s Portfolio VVUS Stock Details VVUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,620
Closed -$96K – 1562
2014
Q1 		$96K Buy
+1,620
New +$115K ﹤0.01% 1345
2013
Q3 		– Sell
-2,525
Closed -$318K – 1443
2013
Q2 		$318K Buy
+2,525
New +$326K 0.01% 903

Other funds holding VVUS

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Oppenheimer & Co's VVUS Position: Q2 2014 in Review

Oppenheimer & Co sold out of Vivus Inc (VVUS) in Q2 2014, closing a stake of 1,620 shares — an estimated $96K sold.

Oppenheimer & Co first reported a position in VVUS in Q2 2013 and held it in 2 quarters. The position peaked at $318K in Q2 2013. 130 funds tracked by Wall St. Rank hold VVUS as of Q2 2014.

  • Oppenheimer & Co reported no remaining Vivus Inc position as of Q2 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 1,620 Vivus Inc shares in Q2 2014, an estimated $96K.
  • Oppenheimer & Co first reported a position in Vivus Inc in Q2 2013 and held it in 2 quarters.
  • Oppenheimer & Co's Vivus Inc position peaked at $318K in Q2 2013.
  • 130 funds tracked by Wall St. Rank held Vivus Inc as of Q2 2014.

Based on Oppenheimer & Co's 13F filing for Q2 2014, filed 14 Aug 2014.